Source comparison
How MK-677 Stacks Up: A Comparison of Secretagogues
To better illustrate where MK-677 fits, it’s helpful to compare it directly to other popular growth hormone secretagogues used in research. Each has a unique profile, and seeing them side-by-side clarifies the landscape. Our experience shows that researchers o
This comparison does not assign a generated winner or score.
- To better illustrate where MK-677 fits, it’s helpful to compare it directly to other popular growth hormone secretagogues used in research. Each has a unique profile, and seeing them side-by-side clarifies the landscape. Our experience shows that researchers often choose a compound based not just on its primary effect but also on its administration route, half-life, and molecular type.
- Compound Type
- Non-Peptide Spiropiperidine
- Synthetic Peptide
- Synthetic Peptide Analog
- Primary Mechanism
- Ghrelin Receptor Agonist
- GHRH Analog
- Administration
- Oral
- Subcutaneous Injection
- Half-Life
- Approx. 24 hours
- Approx. 2 hours
- Approx. 30 minutes
- Approx. 6-8 days
- Effect on Cortisol
- Can slightly increase
- Virtually none
- Can moderately increase
- Minimal
- Effect on Hunger
- Significant increase
- This table makes the differences stark. You can immediately see the primary advantage of MK-677: its oral bioavailability and long half-life, which sets it apart from the peptide-based options like GHRP-6 or the popular CJC-1295/Ipamorelin stack. Those require injections and have much shorter active periods in the body, resulting in more distinct pulses. Conversely, compounds like CJC-1295 work on an entirely different receptor (the Growth Hormone-Releasing Hormone receptor), offering another pathway to stimulate GH release. The choice between them depends entirely on the specific goals and parameters of a research study.